Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity

Keyphrases

• Cannabinoid Receptor 1 (CB1R) 100%
• Receptor Blockade 100%
• Cystitis 100%
• Bladder 83%
• Endocannabinoid System 66%
• Lower Urinary Tract Symptoms 50%
• JD5037 50%
• Peripherally Restricted 33%
• Body Weight Ratio 33%
• Bladder Pain Syndrome 33%
• Void Spot Assay 33%
• Inflammatory Cytokines 16%
• Mouse Model 16%
• Physiological Role 16%
• Clinical Application 16%
• Tumor Necrosis Factor-α 16%
• C57BL 16%
• Therapeutic Potential 16%
• Beneficial Effects 16%
• Inflammatory Response 16%
• Consecutive Days 16%
• Cyclophosphamide 16%
• Gene Expression Level 16%
• Protein Expression Level 16%
• Young Female 16%
• Therapeutic Relevance 16%
• Cannabinoid 1 Receptor Antagonist 16%
• Urination 16%
• Preclinical Development 16%
• Endocannabinoid Levels 16%
• Receptor Antagonism 16%
• Bladder Function 16%

Medicine and Dentistry

• Cannabinoid 1 Receptor 100%
• Receptor Blocking 100%
• Cystitis 100%
• Bladder 83%
• Endocannabinoid System 66%
• Lower Urinary Tract Symptom 50%
• Body Weight 33%
• Bladder Dysfunction 33%
• Urination 33%
• Cyclophosphamide-Induced Cystitis 33%
• Gene Expression 16%
• Cytokine 16%
• C57BL/6 16%
• Serositis 16%
• Endocannabinoid 16%
• Tumor Necrosis Factor 16%
• Cyclophosphamide 16%
• Protein Expression 16%
• Cannabinoid 1 Receptor Antagonist 16%
• Bladder Function 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Cannabinoid 1 Receptor 100%
• Cystitis 100%
• Endocannabinoid System 66%
• Lower Urinary Tract Symptom 50%
• Bladder Dysfunction 33%
• Cyclophosphamide-Induced Cystitis 33%
• Mouse Model 16%
• Tumor Necrosis Factor 16%
• Inflammation 16%
• Cytokine 16%
• Endocannabinoid 16%
• Cyclophosphamide 16%
• C57BL 6 Mouse 16%
• Cannabinoid 1 Receptor Antagonist 16%